HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 259 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $78,055,812 | +22.0% | 674,698 | +8.4% | 0.16% | +26.4% |
Q2 2023 | $63,994,709 | +46.5% | 622,214 | +55.4% | 0.12% | +34.4% |
Q1 2023 | $43,691,035 | -17.8% | 400,321 | -14.3% | 0.09% | -22.5% |
Q4 2022 | $53,177,716 | -65.7% | 467,291 | -81.4% | 0.12% | -64.7% |
Q3 2022 | $155,118,000 | +1127.2% | 2,506,329 | +1481.3% | 0.34% | +1207.7% |
Q2 2022 | $12,640,000 | -81.7% | 158,495 | -75.9% | 0.03% | -80.2% |
Q1 2022 | $69,239,000 | -61.2% | 658,106 | -60.3% | 0.13% | -60.3% |
Q4 2021 | $178,522,000 | +3719.5% | 1,656,679 | +3782.6% | 0.33% | +1636.8% |
Q3 2021 | $4,674,000 | +1540.0% | 42,669 | +1277.8% | 0.02% | +1800.0% |
Q1 2021 | $285,000 | -94.8% | 3,097 | -95.9% | 0.00% | -96.7% |
Q4 2020 | $5,531,000 | +616.5% | 75,619 | +661.1% | 0.03% | +500.0% |
Q3 2020 | $772,000 | -87.8% | 9,935 | -91.3% | 0.01% | -88.6% |
Q2 2020 | $6,350,000 | +193.7% | 114,242 | +39.7% | 0.04% | +340.0% |
Q1 2019 | $2,162,000 | – | 81,790 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,462,634 | $175,978,000 | 7.18% |
SCOPIA CAPITAL MANAGEMENT LP | 4,221,585 | $114,954,000 | 6.73% |
JW Asset Management, LLC | 270,775 | $7,373,000 | 6.49% |
KOPP INVESTMENT ADVISORS LLC | 104,462 | $2,845,000 | 5.23% |
1492 Capital Management LLC | 171,621 | $4,673,000 | 4.56% |
Avoro Capital Advisors LLC | 4,000,000 | $108,920,000 | 4.54% |
Paulson & Co. | 8,170,700 | $222,488,000 | 4.46% |
Rhenman & Partners Asset Management AB | 1,025,000 | $27,911,000 | 3.50% |
Redwood Investments, LLC | 1,376,066 | $37,470,000 | 2.88% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 218,000 | $5,938,000 | 2.74% |